$BRVO
Bravo Multinational Inc.

2023 Q3 Form 10-Q Financial Statement

#000109181823000140 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $110.0K $73.84K $127.1K
YoY Change -13.47% -41.88% -0.4%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $107.7K $73.84K $127.1K
YoY Change -15.26% -41.88% -0.39%
Operating Profit -$127.1K
YoY Change -0.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $4.528M -$73.84K -$127.1K
YoY Change -3661.44% -41.88% -0.46%
Income Tax $0.00
% Of Pretax Income
Net Earnings $4.528M -$73.84K -$127.1K
YoY Change -3661.43% -41.88% -0.46%
Net Earnings / Revenue
Basic Earnings Per Share -$0.09 $0.00 $0.00
Diluted Earnings Per Share -$0.09 $0.00 -$2.667K
COMMON SHARES
Basic Shares Outstanding 47.64M shares 47.64M shares 47.64M shares
Diluted Shares Outstanding 47.95M shares 47.64M shares 47.64M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K $2.540K $30.00
YoY Change 9900.0% 8366.67% -80.0%
Cash & Equivalents $2.535K $2.540K $33.00
Short-Term Investments
Other Short-Term Assets $30.00K $29.33K $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses $29.33K
Receivables $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $31.86K $31.86K $33.00
YoY Change 30832.04% 96445.45% -86.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $31.86K $31.86K $33.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $31.86K $31.86K $33.00
YoY Change 30832.04% 96445.45% -86.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00K $8.940K $400.00
YoY Change 5614.29% 2135.0% -99.6%
Accrued Expenses $160.0K $119.8K $1.300M
YoY Change -88.72% -90.79% 57.58%
Deferred Revenue
YoY Change
Short-Term Debt $120.0K $66.23K $177.7K
YoY Change -35.53% -62.73% 34.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $350.0K $230.7K $1.514M
YoY Change -78.67% -84.76% 38.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $350.0K $230.7K $1.514M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $230.7K $230.7K $1.514M
YoY Change -85.94% -84.76% 38.51%
SHAREHOLDERS EQUITY
Retained Earnings -$91.16M -$90.69M
YoY Change 0.38%
Common Stock $4.763K $89.17M
YoY Change -99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$198.9K -$198.9K -$1.514M
YoY Change
Total Liabilities & Shareholders Equity $31.86K $31.86K $33.00
YoY Change 30832.04% 96445.45% -86.8%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $4.528M -$73.84K -$127.1K
YoY Change -3661.43% -41.88% -0.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$40.00K -$52.69K -$7.990K
YoY Change 373.93% 559.45% -44.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 50.00K 55.18K 7.960K
YoY Change 488.24% 593.22% -6.24%
NET CHANGE
Cash From Operating Activities -40.00K -52.69K -7.990K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 50.00K 55.18K 7.960K
Net Change In Cash 10.00K 2.490K -30.00
YoY Change 16566.67% -8400.0% -99.5%
FREE CASH FLOW
Cash From Operating Activities -$40.00K -$52.69K -$7.990K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001444839
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2023Q3 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2022Q4 brvo Notes Receivable Related Party
NotesReceivableRelatedParty
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
usd
brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
usd
CY2023Q2 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
CY2022Q4 brvo Net Notes Receivable Related Parties
NetNotesReceivableRelatedParties
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-53505
dei Entity Registrant Name
EntityRegistrantName
BRAVO MULTINATIONAL INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4068651
dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
dei City Area Code
CityAreaCode
(757)
dei Local Phone Number
LocalPhoneNumber
306-6090
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
BRVO
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47641010 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2535 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
29325 usd
CY2023Q2 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 usd
CY2023Q2 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
31860 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
73 usd
CY2023Q3 us-gaap Assets
Assets
31860 usd
CY2022Q4 us-gaap Assets
Assets
73 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
8936 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
750 usd
CY2023Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 usd
CY2023Q3 brvo Due To Related Parties
DueToRelatedParties
66230 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
119750 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1537417 usd
CY2023Q3 us-gaap Liabilities
Liabilities
230716 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1767537 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4763 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90954399 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89168493 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91158018 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90940720 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-198856 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1767464 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31860 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4046 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2054 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5423 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4880 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
26040 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
6250 usd
us-gaap Professional Fees
ProfessionalFees
49375 usd
us-gaap Professional Fees
ProfessionalFees
31915 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
43750 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
118750 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
162500 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
237500 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
73836 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
127054 usd
us-gaap Operating Expenses
OperatingExpenses
217298 usd
us-gaap Operating Expenses
OperatingExpenses
274295 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73836 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
127054 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
217298 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
274295 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
73836 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
127054 usd
us-gaap Profit Loss
ProfitLoss
217298 usd
us-gaap Profit Loss
ProfitLoss
274295 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47641010 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47641010 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Net Income Loss
NetIncomeLoss
-217298 usd
us-gaap Net Income Loss
NetIncomeLoss
-274295 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
29325 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-40 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8186 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-367 usd
brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
162500 usd
brvo Increase Decrease In Accrued Board Of Directors Fees
IncreaseDecreaseInAccruedBoardOfDirectorsFees
237500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75937 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37122 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
78398 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
37062 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78398 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37062 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2461 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-60 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2534 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33 usd
brvo Accrued Board Of Directors Fees Contributed To Capital
AccruedBoardOfDirectorsFeesContributedToCapital
1580167 usd
brvo Due To Related Parties Contributed To Capital
DueToRelatedPartiesContributedToCapital
205739 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1239506 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-147241 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1386747 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-127054 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1513801 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1767464 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-143462 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1910926 usd
CY2023Q2 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1785906 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73836 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-198856 usd
brvo Net Royalty Percentage
NetRoyaltyPercentage
0.15 pure
CY2023Q2 us-gaap Area Of Land
AreaOfLand
76.63 acre
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_ztLF80PeEDnc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zNnBGiMdC2jl">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
42312 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2017Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 usd
us-gaap Proceeds Accounts Receivable Previously Written Off Recovery
ProceedsAccountsReceivablePreviouslyWrittenOffRecovery
42312 usd
CY2023Q2 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2022Q4 brvo Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 usd
CY2023Q2 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2022Q4 brvo Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 usd
CY2023Q2 brvo Due To Related Parties
DueToRelatedParties
66230 usd
CY2022Q4 brvo Due To Related Parties
DueToRelatedParties
193570 usd
CY2023Q2 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
870 usd
brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
870 usd
CY2022Q2 brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
brvo Amount Of Press Release Wire Services
AmountOfPressReleaseWireServices
0 usd
CY2023Q2 brvo Filing Fees
FilingFees
930 usd
brvo Filing Fees
FilingFees
930 usd
CY2022Q2 brvo Filing Fees
FilingFees
0 usd
brvo Filing Fees
FilingFees
0 usd
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 brvo Shares Authorized
SharesAuthorized
1050000000 shares
CY2023Q2 us-gaap Shares Issued
SharesIssued
4516667 shares
CY2023Q2 brvo Rent Expense
RentExpense
0 usd
brvo Rent Expense
RentExpense
0 usd
CY2022Q2 brvo Rent Expense
RentExpense
0 usd
brvo Rent Expense
RentExpense
0 usd

Files In Submission

Name View Source Status
0001091818-23-000140-index-headers.html Edgar Link pending
0001091818-23-000140-index.html Edgar Link pending
0001091818-23-000140.txt Edgar Link pending
0001091818-23-000140-xbrl.zip Edgar Link pending
brvo-20230630.xsd Edgar Link pending
brvo20230630.htm Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
brvo-20230630_def.xml Edgar Link unprocessable
brvo-20230630_lab.xml Edgar Link unprocessable
brvo-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brvo20230630_htm.xml Edgar Link completed
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brvo-20230630_cal.xml Edgar Link unprocessable